West Pharmaceutical
754 hedge funds and large institutions have $25.7B invested in West Pharmaceutical in 2023 Q3 according to their latest regulatory filings, with 83 funds opening new positions, 242 increasing their positions, 302 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
754
Holders Change
+23
Holders Change %
+3.15%
% of All Funds
12.02%
Holding in Top 10
9
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-10%
% of All Funds
0.14%
New
83
Increased
242
Reduced
302
Closed
51
Calls
$89.2M
Puts
$72.9M
Net Calls
+$16.3M
Net Calls Change
-$9.24M
Top Buyers
Top Sellers
| 1 |
1
T. Rowe Price Associates
Baltimore,
Maryland
|
$941M |
| 2 |
2
Millennium Management
New York
|
$11.8M |
| 3 |
3
Man Group
London,
United Kingdom
|
$91.5M |
| 4 |
4
Aberdeen Group
Edinburgh,
United Kingdom
|
$53.6M |
| 5 |
5
Invesco
Atlanta,
Georgia
|
$293M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BG
801
Bollard Group
Boston,
Massachusetts
| – | -$2K | -5 | Closed |
|
802
1832 Asset Management
Toronto,
Ontario, Canada
| – | -$1.91K | -5 | Closed |
|
|
FA
803
Fiduciary Alliance
Greenville,
South Carolina
| – | -$1.91K | -5 | Closed |
|
|
M
804
MOTCO
San Antonio,
Texas
| – | -$382 | -1 | Closed |
|